跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
AFINITOR everolimus 5 mg dispersible tablet blister pack
Approved
STANDARD
AFINITOR everolimus 5 mg dispersible tablet blister pack
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
38c31dd74302b0a2
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
38c31dd74302b0a2
Product Name
AFINITOR everolimus 5 mg dispersible tablet blister pack
Artg Id
200205
Artg Name
AFINITOR everolimus 5 mg dispersible tablet blister pack
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2013-08-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d0b750f3ab0a56010c4f4a5005e8fc3d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/f78a81038f5e1d1d891de9b9ee597382.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
38c31dd74302b0a2
Type
Standard
Back to TGA Approvals
AFINITOR everolimus 5 mg dispersible tablet blister pack - TGA Drug Approval Details
